-+ 0.00%
-+ 0.00%
-+ 0.00%

Lion (TSE:4912) Draws Valuation Focus, Is The Recent Pullback A Bargain?

Simply Wall St·08/05/2026 09:38:33
Listen to the news

Lion (TSE:4912) has drawn fresh investor attention after recent price moves. The stock is down 5.6% over the past week and down about 3.1% over the past month.

See our latest analysis for Lion.

Despite the recent 5.6% decline in the 7 day share price and a softer 30 day share price return, Lion’s 90 day share price return of 7.82% and 1 year total shareholder return of 13.75% suggest momentum has cooled rather than reversed.

If Lion’s recent moves have you reassessing your watchlist, it could be a good moment to scan the market for other opportunities through the 10 top founder-led companies

After that pullback, Lion still sits above where it started the year, which leaves a simple fork in the road: Is most of the easy upside already priced in, or is the recent weakness setting up further value ahead?

Most Popular Narrative: 14.6% Undervalued

The most followed narrative currently places Lion’s fair value at ¥1,960.83, compared with the last close of ¥1,675.5. That gap rests on some clear operating priorities.

Lion Corporation is focusing on strengthening its Oral Health Care segment as a top priority and aims for an 8% annual growth rate in this area. This strategic emphasis on high-margin Oral Health Care products is expected to positively impact both revenue and net margins.

Read the complete narrative.

There is a detailed playbook behind that valuation gap. It blends gradual revenue growth, steady earnings progress and a richer profit mix from higher margin categories. The key is how those moving parts line up over the next few years.

Result: Fair Value of ¥1,960.83 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Lion’s reliance on overseas expansion and a shift toward higher margin products could disappoint if execution stumbles or if consumer demand in key markets softens.

Find out about the key risks to this Lion narrative.

Another View On Lion’s Valuation

The narrative fair value points to Lion looking 14.6% undervalued at ¥1,675.5, yet the market is not treating it as a clear bargain on simple earnings terms. The current P/E of 16.7x sits slightly above the Asian Household Products average of 16.1x and below a fair ratio estimate of 23.2x. That mix of modest premium to the sector and discount to the fair ratio leaves an open question. Is the market cautiously right sizing expectations, or leaving room for upside if Lion keeps executing on its plan?

For a closer look at how this pricing stacks up against peers, and what the gap to the fair ratio might mean in practice, See what the numbers say about this price — find out in our valuation breakdown.

TSE:4912 P/E Ratio as at Aug 2026
TSE:4912 P/E Ratio as at Aug 2026

Next Steps

With mixed signals around Lion and its valuation, it makes sense to look past headlines and weigh both the caution and the potential for yourself. If you want to see a concise breakdown of what stands out on each side, take a look at the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Lion?

If Lion has sharpened your focus on where to put fresh capital, do not stop here. The market holds plenty of other opportunities worth a closer look.

Use the Simply Wall Street Screener to uncover stocks that fit your style before they move out of reach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.